NCT06290466 2024-03-04Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy SubjectsAhon Pharmaceutical Co., Ltd.Phase 1 Completed18 enrolled
NCT05439499 2022-07-06This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.Ahon Pharmaceutical Co., Ltd.Phase 3 Unknown434 enrolled